Valuation: IXICO plc

Market Cap 16.9M 22.97M 19.71M 18.49M 31.87M 2.19B 32.01M 219M 84.66M 1.11B 86.16M 84.37M 3.66B P/E 2026 *
-5.54x
P/E 2027 * -5.96x
Enterprise Value 6.7M 9.11M 7.81M 7.33M 12.64M 869M 12.69M 86.7M 33.56M 438M 34.16M 33.45M 1.45B EV / Sales 2026 *
0.84x
EV / Sales 2027 * 1.2x
Free-Float
89.22%
Yield 2026 *
-
Yield 2027 * -
1 week+3.33%
Current month-3.12%
1 month-8.82%
3 months-11.43%
6 months+1.64%
Current year-34.04%
1 week 7
Extreme 7
8.5
1 month 7
Extreme 7
9
Current year 6.26
Extreme 6.26
12
1 year 6.26
Extreme 6.26
15
3 years 6.26
Extreme 6.26
21
5 years 6.26
Extreme 6.26
92
10 years 6.26
Extreme 6.26
127
Manager TitleAgeSince
Chief Executive Officer 53 19/08/2024
Director of Finance/CFO 50 21/08/2019
Chief Tech/Sci/R&D Officer - 01/06/2025
Director TitleAgeSince
Chairman 51 -
Director/Board Member 50 21/08/2019
Director/Board Member 60 21/01/2022
Date Insider Type Main position Quantity % Market Cap.
15/7/26 Buy

Chairman

50,006 0.0228%
13/6/25 Free 350,000 0.3777%
13/6/25 Free 350,000 0.3777%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%+3.33%-36.73%-61.82% 23.04M
-1.01%+3.89%+2.62%+24.19% 51.65B
+1.92%-0.26%+503.98%+550.09% 45.31B
+0.81%+8.95%+39.09%+19.41% 42.7B
-0.15%+1.80%+21.76%+89.41% 42.79B
-2.27%-3.02%+14.22%+51.50% 32.87B
+0.81%+4.87%+32.62%+138.26% 17.14B
-1.08%+0.56% - - 16.61B
-1.70%+4.54%+9.11%+30.36% 15.01B
-0.85%+5.70%+79.82%+47.26% 14.21B
Average -0.49%+3.01%+74.05%+98.74% 27.83B
Weighted average by Cap. -0.42%+2.74%+106.48%+137.62%

Financials

2026 *2027 *
Net sales 8M 10.88M 9.33M 8.75M 15.09M 1.04B 15.15M 104M 40.08M 523M 40.79M 39.94M 1.73B 9M 12.24M 10.49M 9.85M 16.98M 1.17B 17.05M 116M 45.09M 589M 45.89M 44.94M 1.95B
Net income -2.14M -2.91M -2.5M -2.35M -4.04M -278M -4.06M -27.74M -10.74M -140M -10.93M -10.7M -464M -2.8M -3.81M -3.27M -3.07M -5.28M -363M -5.31M -36.25M -14.03M -183M -14.28M -13.98M -606M
Net Debt -10.2M -13.87M -11.89M -11.16M -19.24M -1.32B -19.32M -132M -51.1M -667M -52.01M -50.93M -2.21B -6.1M -8.29M -7.11M -6.68M -11.51M -791M -11.56M -78.95M -30.56M -399M -31.1M -30.46M -1.32B
Logo IXICO plc
IXICO plc is engaged in neuroscience imaging and biomarker analytics, using its artificial intelligence (AI)-driven platform to help advance drug development in neurological disorders. The Company is engaged in delivering insights in neuroscience to help transform the advancement of investigational therapies for neurological diseases, such as Alzheimer's disease, Parkinson's disease and Huntington's disease. It advances medicine and human health by turning data into clinically meaningful information, providing new insights in neuroscience by supporting pharmaceutical companies across all phases of central nervous system (CNS) clinical research. Its services include imaging biomarkers, trial management, data analytics, consultancy and post-marketing surveillance. Its TrialTracker platform provides a standardized, compliant and efficient workflow for capturing visual read results of MRI, SPECT, PET and CT scans, supporting single, over-read and double adjudicated read paradigms.
Employees
79
Date Price Change Volume
26/08/26 GBX 7.750 0.00% 8,219
25/08/26 GBX 7.750 0.00% 0
24/08/26 GBX 7.750 +3.33% 30,172
21/08/26 GBX 7.500 0.00% 14,386
20/08/26 GBX 7.500 0.00% 1,669
Trader
-
Investor
-
Global
-
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.0775GBP
Average target price
0.2600GBP
Spread / Average Target
+235.48%

Annual profits - Rate of surprise